Peer-influenced content. Sources you trust. No registration required. This is HCN.
The New England Journal of Medicine
Reevaluating beta-blocker therapy post-myocardial infarction, a recent trial found no significant difference in the composite primary endpoint of death from any cause or new myocardial infarction between patients treated with long-term beta-blockers and those without.
Cardiology April 15th 2024
CME 
JOBS 
OUTBREAKS 
PEER-TO-PEER 
QUIZZES & QUESTIONS 
MEDTECH